These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30038517)

  • 1. Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway.
    Xia E; Zhou X; Bhandari A; Zhang X; Wang O
    Cancer Manag Res; 2018; 10():1575-1583. PubMed ID: 30038517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.
    Ye G; Tu L; Li Z; Li X; Zheng X; Song Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 38038167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptopodin-2: a potential tumor suppressor.
    Zheng Z; Song Y
    Cancer Cell Int; 2023 Aug; 23(1):158. PubMed ID: 37544991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
    Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
    Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation.
    Gao J; Zhang HP; Sun YH; Guo WZ; Li J; Tang HW; Guo DF; Zhang JK; Shi XY; Yu DS; Zhang XD; Wen PH; Shi JH; Zhang SJ
    Cancer Lett; 2020 Jul; 482():8-18. PubMed ID: 32278815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
    Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
    J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
    Yang Q; Ji G; Li J
    Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers.
    Hossain MS; Quadery Tonmoy MI; Islam MN; Islam MS; Afif IK; Singha Roy A; Fariha A; Al Reza H; Bahadur NM; Rahaman MM
    Heliyon; 2021 Jun; 7(6):e07347. PubMed ID: 34195444
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Bhandari A; Xia E; Zhou Y; Guan Y; Xiang J; Kong L; Wang Y; Yang F; Wang O; Zhang X
    Cancer Manag Res; 2018; 10():969-976. PubMed ID: 29760566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
    Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
    Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.
    Wander SA; Zhao D; Besser AH; Hong F; Wei J; Ince TA; Milikowski C; Bishopric NH; Minn AJ; Creighton CJ; Slingerland JM
    Breast Cancer Res Treat; 2013 Apr; 138(2):369-81. PubMed ID: 23430223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
    Cai M; Li H; Chen R; Zhou X
    Cancer Manag Res; 2021; 13():2009-2024. PubMed ID: 33658859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
    Ni J; Peng Y; Yang FL; Xi X; Huang XW; He C
    Onco Targets Ther; 2018; 11():3303-3312. PubMed ID: 29892197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer.
    Wang T; Zhou T; Fu F; Han Y; Li Y; Yuan M
    Dis Markers; 2022; 2022():7466555. PubMed ID: 36479041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.